EIR Nesher Pharmaceuticals (USA) Apr 2007

Sharon Thoma FDA$595.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Saint Louis, MO, United States facility and issued inspectional observation (via FDA 483) on 20 Apr 2007.

Product details

  • Category:
  • Inspection end: 20 Apr 2007
  • Location: Saint Louis, United States
  • FEI: 1937079
Add To Cart